Eledon Pharmaceuticals Statistics
NASDAQ: ELDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.78-0.12 (-6.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Eledon Pharmaceuticals by the numbers
Eledon Pharmaceuticals has a market capitalization of $150.3 million based on 84.46M shares outstanding. With trailing EPS of $-0.73, Eledon Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.8% below its 50-day average and 43.0% below its 200-day average.
Average daily trading volume is 931.77K shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELDN valuation vs. peer median
| Metric | ELDN | Peer median | Difference |
|---|---|---|---|
| Market cap | $150.34M | $148.17M | +1% |
| Avg. volume | 931.77K | 464.38K | +101% |
Peer median across 8 companies: RNA, IFRX, VRXA, PRQR, ORMP, BBOT, EMIS, ALXO.
Valuation
- Market cap
- $150.34M
- EPS (TTM)
- $-0.73
- Shares outstanding
- 84.46M
Price and trading
- Previous close
- 1.90
- Open
- 1.87
- Day range
- 1.76 – 2.00
- 52-week range
- 1.39 – 4.49
- 52-week change
- +23.61%
- Beta
- —
- Volume
- 1.29M
- Average volume
- 931.77K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 150.34M
- Forward Pe
- -2.35
- Eps
- -0.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.49
- Week52 Low
- 1.39
- Avg Volume
- 931.77K
- Shares Outstanding
- 84.46M
- Ma50
- 2.47
- Ma200
- 3.12
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -60.36%
- Pct From52w Low
- 28.52%